AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

Unexplained bruising could indicate leukemia. Learn 8 key warning signs that distinguish normal bruising from serious blood ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Driven, athletic, and a role model to his community, 20-year-old Eddie Kaufman has been fighting an aggressive form of blood ...

While Virtus Bologna is fighting for the Scudetto against Brescia, Achille Polonara, 33, has been diagnosed with myeloid ...

This 'Forgotten' Blood Test Can Catch Cancer Early first appeared on Parade on Jun 15, 2025 This story was originally ...

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the ...

Blood Test Could Make Cancer Treatments ... could have implications for the treatment of acute myeloid leukemia and ... How Breast Cancer Cells Survive in Bone Marrow After Remission Dec.

"Mighty Matteo" was diagnosed with B-cell acute lymphoblastic leukemia, a rare blood cancer, last year. CBS News New York's ...

The AbbVie-Roche cancer drug venetoclax failed to meet its primary endpoint in a phase 3 trial to treat newly diagnosed ...